SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001601830-24-000019
Filing Date
2024-02-29
Accepted
2024-02-29 08:25:26
Documents
177
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rxrx-20231231.htm   iXBRL 10-K 2327489
2 EX-4.2 exhibit42-descriptionofsec.htm EX-4.2 32099
3 EX-10.21 exhibit1021-rxrxxbayeragre.htm EX-10.21 766040
4 EX-21.1 exhibit211-10xk2023.htm EX-21.1 6419
5 EX-23.1 exhibit231-eyconsent.htm EX-23.1 5753
6 EX-31.1 exhibit311-10xk23.htm EX-31.1 7153
7 EX-31.2 exhibit312-10xk23.htm EX-31.2 7141
8 EX-32.1 exhibit321-10xk23.htm EX-32.1 3359
9 EX-97.1 exhibit971-clawbackpolicy.htm EX-97.1 39592
15 rxrx-20231231_g1.jpg GRAPHIC 79870
16 rxrx-20231231_g10.jpg GRAPHIC 248669
17 rxrx-20231231_g11.jpg GRAPHIC 146799
18 rxrx-20231231_g12.jpg GRAPHIC 226391
19 rxrx-20231231_g13.jpg GRAPHIC 299972
20 rxrx-20231231_g14.jpg GRAPHIC 325005
21 rxrx-20231231_g15.jpg GRAPHIC 401283
22 rxrx-20231231_g16.jpg GRAPHIC 619122
23 rxrx-20231231_g17.jpg GRAPHIC 826892
24 rxrx-20231231_g18.jpg GRAPHIC 238809
25 rxrx-20231231_g19.jpg GRAPHIC 1284595
26 rxrx-20231231_g2.jpg GRAPHIC 106472
27 rxrx-20231231_g20.jpg GRAPHIC 1367821
28 rxrx-20231231_g21.jpg GRAPHIC 472978
29 rxrx-20231231_g22.jpg GRAPHIC 482391
30 rxrx-20231231_g23.jpg GRAPHIC 407890
31 rxrx-20231231_g24.jpg GRAPHIC 209183
32 rxrx-20231231_g25.jpg GRAPHIC 266122
33 rxrx-20231231_g26.jpg GRAPHIC 971271
34 rxrx-20231231_g27.jpg GRAPHIC 272462
35 rxrx-20231231_g28.jpg GRAPHIC 304482
36 rxrx-20231231_g29.jpg GRAPHIC 305421
37 rxrx-20231231_g3.jpg GRAPHIC 97626
38 rxrx-20231231_g30.jpg GRAPHIC 267755
39 rxrx-20231231_g31.jpg GRAPHIC 853280
40 rxrx-20231231_g32.jpg GRAPHIC 495553
41 rxrx-20231231_g33.jpg GRAPHIC 111296
42 rxrx-20231231_g34.jpg GRAPHIC 301641
43 rxrx-20231231_g35.jpg GRAPHIC 336701
44 rxrx-20231231_g36.jpg GRAPHIC 396182
45 rxrx-20231231_g37.jpg GRAPHIC 163995
46 rxrx-20231231_g38.jpg GRAPHIC 1164090
47 rxrx-20231231_g39.jpg GRAPHIC 407213
48 rxrx-20231231_g4.jpg GRAPHIC 110458
49 rxrx-20231231_g40.jpg GRAPHIC 375053
50 rxrx-20231231_g41.jpg GRAPHIC 380661
51 rxrx-20231231_g42.jpg GRAPHIC 689155
52 rxrx-20231231_g43.jpg GRAPHIC 123516
53 rxrx-20231231_g44.jpg GRAPHIC 265732
54 rxrx-20231231_g45.jpg GRAPHIC 199871
55 rxrx-20231231_g46.jpg GRAPHIC 359938
56 rxrx-20231231_g47.jpg GRAPHIC 446263
57 rxrx-20231231_g48.jpg GRAPHIC 224175
58 rxrx-20231231_g49.jpg GRAPHIC 363114
59 rxrx-20231231_g5.jpg GRAPHIC 99575
60 rxrx-20231231_g50.jpg GRAPHIC 199477
61 rxrx-20231231_g51.jpg GRAPHIC 289363
62 rxrx-20231231_g52.jpg GRAPHIC 159411
63 rxrx-20231231_g53.jpg GRAPHIC 291509
64 rxrx-20231231_g54.jpg GRAPHIC 282331
65 rxrx-20231231_g55.jpg GRAPHIC 262820
66 rxrx-20231231_g56.jpg GRAPHIC 158425
67 rxrx-20231231_g57.jpg GRAPHIC 464103
68 rxrx-20231231_g58.jpg GRAPHIC 353308
69 rxrx-20231231_g59.jpg GRAPHIC 499285
70 rxrx-20231231_g6.jpg GRAPHIC 569821
71 rxrx-20231231_g60.jpg GRAPHIC 21120
72 rxrx-20231231_g61.jpg GRAPHIC 21353
73 rxrx-20231231_g62.jpg GRAPHIC 662304
74 rxrx-20231231_g63.jpg GRAPHIC 134549
75 rxrx-20231231_g64.jpg GRAPHIC 305680
76 rxrx-20231231_g65.jpg GRAPHIC 317108
77 rxrx-20231231_g66.jpg GRAPHIC 113654
78 rxrx-20231231_g67.jpg GRAPHIC 184097
79 rxrx-20231231_g68.jpg GRAPHIC 164284
80 rxrx-20231231_g69.jpg GRAPHIC 295157
81 rxrx-20231231_g7.jpg GRAPHIC 2480277
82 rxrx-20231231_g70.jpg GRAPHIC 361871
83 rxrx-20231231_g71.jpg GRAPHIC 249208
84 rxrx-20231231_g72.jpg GRAPHIC 408782
85 rxrx-20231231_g73.jpg GRAPHIC 310154
86 rxrx-20231231_g74.jpg GRAPHIC 151915
87 rxrx-20231231_g75.jpg GRAPHIC 5522177
88 rxrx-20231231_g76.jpg GRAPHIC 282532
89 rxrx-20231231_g77.jpg GRAPHIC 2238829
90 rxrx-20231231_g78.jpg GRAPHIC 623266
91 rxrx-20231231_g79.jpg GRAPHIC 1676359
92 rxrx-20231231_g8.jpg GRAPHIC 290000
93 rxrx-20231231_g80.jpg GRAPHIC 148476
94 rxrx-20231231_g81.jpg GRAPHIC 2151332
95 rxrx-20231231_g9.jpg GRAPHIC 235250
  Complete submission text file 0001601830-24-000019.txt   116249811

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20231231.xsd EX-101.SCH 56794
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxrx-20231231_cal.xml EX-101.CAL 103275
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20231231_def.xml EX-101.DEF 329432
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20231231_lab.xml EX-101.LAB 851669
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20231231_pre.xml EX-101.PRE 554492
179 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20231231_htm.xml XML 973490
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40323 | Film No.: 24699046
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)